Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients

Zhong-Xiu Wang,Chao Wang,Peng Zhang,Yang Qu,Zhen-Ni Guo,Yi Yang
DOI: https://doi.org/10.3389/fnagi.2020.601471
IF: 4.8
2020-12-04
Frontiers in Aging Neuroscience
Abstract:Background : Intravenous thrombolysis (IVT) therapy is currently one of the best medical treatments available for patients with acute ischemic stroke. Studies have shown that blood pressure (BP) changes in patients treated with IVT are significantly correlated with prognosis. Objective : Our study aimed to determine the relationship between BP changes during recombinant tissue plasminogen activator (rt-PA) infusion and the 3-month prognosis evaluated using the modified Rankin Scale (mRS) and determine the factors influencing BP changes during rt-PA infusion. Methods : Consecutive patients who were treated with IVT and admitted to our stroke center between May 2015 and October 2017 were analyzed retrospectively. Patients were divided into two groups according to their 3-month prognosis status: patients with mRS ≤ 2 were defined as “favorable outcome group” and those with mRS ≥ 3 as “unfavorable outcome group”. First, the factors affecting prognosis after thrombolysis were analyzed. Second, we analyzed the relationship between BP and the prognosis. BP was taken before and at regular intervals of 15 min during the rt-PA infusion (1 h). The average value of BP during thrombolysis was calculated and compared to the baseline BP. BP decrease was defined as the difference between the baseline BP and the average BP, provided it was greater than 0 mmHg. Third, univariate and multivariate analyses were performed to identify factors that may contribute to BP decrease. Results : In total, 458 patients were included. Patients with a lower baseline National Institute of Health Stroke Scale (NIHSS) score (8.25 ± 5.57 vs. 13.51 ± 7.42, P < 0.001), a higher Alberta Stroke Program Early CT Score (ASPECTS; 8.65 ± 1.82 vs. 8.13 ± 2.00, P = 0.005), decreased BP during thrombolysis (69.4% vs. 59.8%, P = 0.037), and steady BP (SD < 10 mmHg) were more likely to have a favorable outcome (73.9% vs. 60.6%, P = 0.019). High baseline BP (OR > 1), hypertension history (OR < 1), and baseline ASPECTS (OR > 1) were independent factors of BP change during thrombolysis. Conclusion : Patients with decreased or steady BP during thrombolysis were more likely to have a favorable outcome. Baseline ASPECTS, baseline NIHSS score, and hypertension history influenced BP changes during thrombolysis.
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore the relationship between blood pressure changes and 3 - month prognosis during intravenous thrombolytic therapy in patients with acute ischemic stroke, and to identify the factors that affect blood pressure changes. Specifically, the study aims to: 1. **Determine the relationship between blood pressure changes and prognosis**: By analyzing the blood pressure changes in patients during the infusion of recombinant tissue - type plasminogen activator (rt - PA), evaluate the relationship between these changes and the modified Rankin Scale (mRS) score 3 months later. 2. **Identify the factors that affect blood pressure changes**: Through univariate and multivariate analyses, determine which factors may affect the blood pressure changes in patients during rt - PA infusion. ### Research Background Intravenous thrombolysis (IVT) is currently one of the most effective medical treatments for acute ischemic stroke. Previous studies have shown that blood pressure changes in patients receiving IVT treatment are significantly related to their prognosis. Therefore, understanding the impact of blood pressure changes on prognosis is helpful to improve the effectiveness of IVT treatment. ### Research Objectives - **Primary objective**: Determine the relationship between blood pressure changes during rt - PA infusion and 3 - month prognosis. - **Secondary objective**: Determine the factors that affect blood pressure changes. ### Methods - **Study design**: Retrospective analysis of consecutive patients who received IVT treatment in the Stroke Center of the First Hospital of Jilin University from May 2015 to October 2017. - **Grouping**: According to the mRS score 3 months later, the patients were divided into a good - prognosis group (mRS ≤2) and a poor - prognosis group (mRS ≥3). - **Blood pressure measurement**: Blood pressure was measured once every 15 minutes before and during rt - PA infusion, the average blood pressure was calculated and compared with the baseline blood pressure. - **Statistical analysis**: Data analysis was performed using SPSS 20.0, including t - test, Pearson chi - square test and binary Logistic regression analysis. ### Results - **Differences between the good - prognosis group and the poor - prognosis group**: - The baseline NIHSS score in the good - prognosis group was lower (8.25 ± 5.57 vs. 13.51 ± 7.42, P < 0.001), and the ASPECTS score was higher (8.65 ± 1.82 vs. 8.13 ± 2.00, P = 0.005). - The proportion of patients with a decrease in blood pressure during thrombolysis was higher in the good - prognosis group (69.4% vs. 59.8%, P = 0.037), and the blood pressure fluctuation was smaller (SD < 10 mmHg). - **Factors that affect blood pressure changes**: - Higher baseline blood pressure (OR > 1), a history of hypertension (OR < 1) and higher baseline ASPECTS score (OR > 1) are independent factors that affect blood pressure changes. ### Conclusions - **Main conclusions**: A decrease or stability in blood pressure during thrombolysis is associated with a good prognosis. Baseline ASPECTS score, baseline NIHSS score and a history of hypertension affect blood pressure changes. - **Clinical significance**: These findings are helpful for predicting the prognosis of patients receiving IVT treatment and suggest that blood pressure control during IVT may improve the clinical outcome. ### Future Directions - **Multicenter prospective study**: More multicenter prospective studies are needed to verify these results in order to obtain more reliable data. - **Use of antihypertensive drugs**: Studies should include patients using antihypertensive drugs in order to provide guidance on blood pressure control for all IVT patients.